EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


facebook twitter youtube
News archive
Recent news

 

Myeloma Patients Europe (MPE) held a webinar on ASH 2020 myeloma and AL amyloidosis highlights on 16 November to review the most recent myeloma research presented at the annual meeting of the American Society of Hematology (ASH) 2020 (5 – 8 December 2020).

The talk will be given by Dr Kaz Groen and Dr Claudia Stege, both from VU University Medical Center in Amsterdam, The Netherlands.

   

   

You can download the slides of this webinar here.







Recent news

» Daratumumab becomes the first FDA-approved treatment for patients with newly diagnosed light chain (AL) amyloidosis

» ASH 2020 AL amyloidosis highlights

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy * for Click to select the duration you give consent until.